Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1991016917) METHOD OF TREATING GASTRIC ULCERS AND OBESITY
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1991/016917 International Application No.: PCT/US1991/002620
Publication Date: 14.11.1991 International Filing Date: 19.04.1991
Chapter 2 Demand Filed: 04.11.1991
IPC:
A61K 38/20 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
19
Cytokines; Lymphokines; Interferons
20
Interleukins
Applicants:
THE UPJOHN COMPANY [US/US]; 301 Henrietta Street Kalamazoo, MI 49001, US (AllExceptUS)
ROBERT, André [US/US]; US (UsOnly)
Inventors:
ROBERT, André; US
Agent:
DELUCA, Mark; The Upjohn Company Corporate Patents & Trademarks Kalamazoo, MI 49001, US
PERRY, Robert, E.; Gill Jennings & Every 53-64 Chancery Lane London WC2A 1HN, GB
Priority Data:
517,63202.05.1990US
Title (EN) METHOD OF TREATING GASTRIC ULCERS AND OBESITY
(FR) PROCEDE DE TRAITEMENT DES ULCERES GASTRIQUES ET DE L'OBESITE
Abstract:
(EN) A method for the treatment or prevention of gastric ulcers in mammals is disclosed. This method comprises administering to a mammal, who is suffering from or is particularly susceptible to said gastric ulcers, an amount of Interleukin-1 effective to cure or prevent said gastric ulcers by inducing a cytoprotective effect. Additionally, a method of treating obesity in mammals is disclosed. The method comprises administering to a human suffering obesity, an effective amount of IL-1 to retard gastric emptying.
(FR) Procédé de traitement ou de prévention des ulcères gastriques chez les mammifères. Le procédé consiste à administrer à un mammifère qui souffre d'ulcères gastriques, ou qui est particulièrement peu résistant à ceux-ci, une quantité suffisante d'interleucine-1 pour guérir ou prévenir lesdits ulcères gastriques au moyen de son effet cytoprotecteur. On décrit également un procédé de traitement de l'obésité chez les mammifères. Le procédé consiste à administrer, à une personne qui souffre de l'obésité, une quantité suffisante d'interleucine-1 pour retarder l'évacuation gastrique.
Designated States: AU, BB, BG, BR, CA, FI, HU, JP, KP, KR, LK, MC, MG, MW, NO, PL, RO, SD, SU, US
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CM, GA, ML, MR, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
AU1991076912